Payment overview · 2025
General Payments
$1,126.36
28 reported records · 14 companies
Healthcare provider profile · identity verified
Jarod Franklin Bailey, D.O.
Allopathic & Osteopathic Physicians|Internal Medicine · VALDOSTA, GA · NPI 1649432733
Verified facts
What the public records show
CMS Open Payments records show Jarod Franklin Bailey, D.O. received $1,126.36 in general payments during 2025 across 28 reported records.
Stryker Corporation accounted for 57.4% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 23 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Mounjaro, Ozempic, Rexulti, Rybelsus.
Astellas Pharma US Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Myrbetriq as an associated drug or biological on 16 records involving 16 distinct recipient NPIs. Public Medicare Part D data also shows 279 claims for Myrbetriq by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 297 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 114 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 143 claims for Trulicity by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 82 claims for Rexulti by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Fiasp as an associated drug or biological on 15 records involving 15 distinct recipient NPIs. Public Medicare Part D data also shows 18 claims for Fiasp by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 161 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Rybelsus by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported ELIQUIS as an associated drug or biological on 87112 records involving 36032 distinct recipient NPIs. Public Medicare Part D data also shows 2343 claims for Eliquis by this doctor in 2024.
PFIZER INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported PAXLOVID as an associated drug or biological on 24465 records involving 15715 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Paxlovid by this doctor in 2024.
SANOFI-AVENTIS U.S. LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LANTUS as an associated drug or biological on 12 records involving 11 distinct recipient NPIs. Public Medicare Part D data also shows 64 claims for Lantus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Stryker Corporation | Unresolved — no canonical attribution shown | $646.07 | 57.4% | 2 | 2025 |
| Abbott Laboratories | Unresolved — no canonical attribution shown | $80.99 | 7.2% | 4 | 2025 |
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $65.90 | 5.8% | 4 | 2025 |
| PFIZER INC. | Unresolved — no canonical attribution shown | $56.29 | 5.0% | 3 | 2025 |
| SANOFI-AVENTIS U.S. LLC | Unresolved — no canonical attribution shown | $52.59 | 4.7% | 3 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $50.70 | 4.5% | 3 | 2025 |
| Seqirus USA Inc | Unresolved — no canonical attribution shown | $32.33 | 2.9% | 2 | 2025 |
| SHIELD THERAPEUTICS INC | Unresolved — no canonical attribution shown | $29.11 | 2.6% | 1 | 2025 |
| Boston Scientific Corporation | Unresolved — no canonical attribution shown | $27.98 | 2.5% | 1 | 2025 |
| Astellas Pharma US Inc | Unresolved — no canonical attribution shown | $23.07 | 2.0% | 1 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $18.03 | 1.6% | 1 | 2025 |
| Paratek Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $16.20 | 1.4% | 1 | 2025 |
| IBSA Pharma Inc. | Unresolved — no canonical attribution shown | $13.56 | 1.2% | 1 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $13.54 | 1.2% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $600.50 | 27 |
| Travel and Lodging | $525.86 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| MAKO Normalized: mako |
Device | Stryker Corporation | $646.07 | 2 | 2025 |
Source payment records
|
|||||
| FREESTYLE LIBRE Normalized: freestyle libre |
Device | Abbott Laboratories | $80.99 | 4 | 2025 |
Source payment records
|
|||||
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $65.90 | 4 | 2025 |
Source payment records
|
|||||
| TZIELD Normalized: tzield |
Biological | SANOFI-AVENTIS U.S. LLC | $52.59 | 3 | 2025 |
Source payment records
|
|||||
| NURTEC ODT Normalized: nurtec odt |
Drug | PFIZER INC. | $39.17 | 2 | 2025 |
Source payment records
|
|||||
| ZAVZPRET Normalized: zavzpret |
Drug | PFIZER INC. | $39.17 | 2 | 2025 |
Source payment records
|
|||||
| Fluad Normalized: fluad |
Biological | Seqirus USA Inc | $32.33 | 2 | 2025 |
Source payment records
|
|||||
| Flucelvax Normalized: flucelvax |
Biological | Seqirus USA Inc | $32.33 | 2 | 2025 |
Source payment records
|
|||||
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $31.74 | 2 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $31.74 | 2 | 2025 |
Source payment records
|
|||||
| ACCRUFER Normalized: accrufer |
Drug | SHIELD THERAPEUTICS INC | $29.11 | 1 | 2025 |
Source payment records
|
|||||
| WATCHMAN Access System Normalized: watchman access system |
Device | Boston Scientific Corporation | $27.98 | 1 | 2025 |
Source payment records
|
|||||
| Veozah Normalized: veozah |
Drug | Astellas Pharma US Inc | $23.07 | 1 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $18.96 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $18.03 | 1 | 2025 |
Source payment records
|
|||||
| ABRYSVO Normalized: abrysvo |
Biological | PFIZER INC. | $17.12 | 1 | 2025 |
Source payment records
|
|||||
| PREVNAR 20 Normalized: prevnar 20 |
Biological | PFIZER INC. | $17.12 | 1 | 2025 |
Source payment records
|
|||||
| NUZYRA Normalized: nuzyra |
Drug | Paratek Pharmaceuticals, Inc. | $16.20 | 1 | 2025 |
Source payment records
|
|||||
| Flector Normalized: flector |
Drug | IBSA Pharma Inc. | $13.56 | 1 | 2025 |
Source payment records
|
|||||
| Licart Normalized: licart |
Drug | IBSA Pharma Inc. | $13.56 | 1 | 2025 |
Source payment records
|
|||||
| Tirosint Normalized: tirosint |
Drug | IBSA Pharma Inc. | $13.56 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $13.54 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $13.54 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 114 | exact normalized | Medicare Part D |
| Ozempic ozempic |
2025 | Ozempic | 2024 | 161 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 82 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| Rybelsus rybelsus |
2025 | Rybelsus | 2024 | 24 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Astellas Pharma US Inc Exact reporting entity; no affiliate inference |
2025 | Myrbetriq open payments reported associated product |
CMS Open Payments — General Payments 16 supporting records · 16 recipient NPIs · example record 1238599014 |
Myrbetriq · 2024 Exact normalized brand match · 1 Part D row |
279 | 17 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
297 | 47 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
114 | 25 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
143 | 29 |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
82 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Fiasp open payments reported associated product |
CMS Open Payments — General Payments 15 supporting records · 15 recipient NPIs · example record 1188262936 |
Fiasp · 2024 Exact normalized brand match · 1 Part D row |
18 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
161 | 36 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | ELIQUIS open payments reported associated product |
CMS Open Payments — General Payments 87112 supporting records · 36032 recipient NPIs · example record 1228794063 |
Eliquis · 2024 Exact normalized brand match · 1 Part D row |
2343 | 195 |
| PFIZER INC. Exact reporting entity; no affiliate inference |
2025 | PAXLOVID open payments reported associated product |
CMS Open Payments — General Payments 24465 supporting records · 15715 recipient NPIs · example record 1228794432 |
Paxlovid · 2024 Exact normalized brand match · 1 Part D row |
29 | 28 |
| SANOFI-AVENTIS U.S. LLC Exact reporting entity; no affiliate inference |
2025 | LANTUS open payments reported associated product |
CMS Open Payments — General Payments 12 supporting records · 11 recipient NPIs · example record 1233196856 |
Lantus · 2024 Exact normalized brand match · 1 Part D row |
64 | 23 |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 5124 | 462 |
| Amlodipine Besylate | Amlodipine Besylate | 4038 | 399 |
| Omeprazole | Omeprazole | 3339 | 296 |
| Pravastatin Sodium | Pravastatin Sodium | 2768 | 235 |
| Levothyroxine Sodium | Levothyroxine Sodium | 2766 | 264 |
| Famotidine | Famotidine | 2546 | 178 |
| Gabapentin | Gabapentin | 2516 | 270 |
| Eliquis | Apixaban | 2343 | 195 |
| Carvedilol | Carvedilol | 2132 | 153 |
| Metoprolol Tartrate | Metoprolol Tartrate | 2084 | 199 |
| Lisinopril | Lisinopril | 2078 | 194 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1989 | 161 |
| Furosemide | Furosemide | 1891 | 202 |
| Potassium Chloride | Potassium Chloride | 1814 | 181 |
| Metoprolol Succinate | Metoprolol Succinate | 1706 | 155 |
| Valsartan | Valsartan | 1689 | 132 |
| Sertraline Hcl | Sertraline Hcl | 1634 | 142 |
| Levetiracetam | Levetiracetam | 1574 | 84 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1573 | 196 |
| Hydralazine Hcl | Hydralazine Hcl | 1571 | 144 |
| Clopidogrel | Clopidogrel Bisulfate | 1520 | 142 |
| Donepezil Hcl | Donepezil Hcl | 1465 | 103 |
| Trazodone Hcl | Trazodone Hcl | 1464 | 137 |
| Montelukast Sodium | Montelukast Sodium | 1185 | 137 |
| Memantine Hcl | Memantine Hcl | 1048 | 66 |
| Mirtazapine | Mirtazapine | 1030 | 84 |
| Allopurinol | Allopurinol | 991 | 87 |
| Metformin Hcl | Metformin Hcl | 970 | 144 |
| Divalproex Sodium | Divalproex Sodium | 875 | 47 |
| Hydrochlorothiazide | Hydrochlorothiazide | 832 | 84 |
| Buspirone Hcl | Buspirone Hcl | 828 | 75 |
| Duloxetine Hcl | Duloxetine Hcl | 806 | 93 |
| Quetiapine Fumarate | Quetiapine Fumarate | 777 | 68 |
| Olanzapine | Olanzapine | 765 | 47 |
| Escitalopram Oxalate | Escitalopram Oxalate | 751 | 72 |
| Finasteride | Finasteride | 695 | 55 |
| Ropinirole Hcl | Ropinirole Hcl | 678 | 39 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 660 | 145 |
| Citalopram Hbr | Citalopram Hydrobromide | 638 | 63 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 584 | 41 |
| Baclofen | Baclofen | 581 | 36 |
| Losartan Potassium | Losartan Potassium | 573 | 131 |
| Bumetanide | Bumetanide | 563 | 50 |
| Risperidone | Risperidone | 554 | 29 |
| Tradjenta | Linagliptin | 500 | 43 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 493 | 36 |
| Lamotrigine | Lamotrigine | 457 | 16 |
| Oxcarbazepine | Oxcarbazepine | 453 | 11 |
| Nifedipine Er | Nifedipine | 447 | 51 |
| Clonidine Hcl | Clonidine Hcl | 439 | 62 |
| Midodrine Hcl | Midodrine Hcl | 432 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 406 | 86 |
| Sucralfate | Sucralfate | 394 | 43 |
| Fluticasone Propionate | Fluticasone Propionate | 386 | 157 |
| Simvastatin | Simvastatin | 385 | 61 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 378 | 16 |
| Pregabalin | Pregabalin | 338 | 73 |
| Xarelto | Rivaroxaban | 337 | 34 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 334 | 102 |
| Lorazepam | Lorazepam | 330 | 72 |
| Atenolol | Atenolol | 320 | 26 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 318 | 35 |
| Spironolactone | Spironolactone | 314 | 44 |
| Prednisone | Prednisone | 300 | 106 |
| Methenamine Hippurate | Methenamine Hippurate | 298 | 15 |
| Jardiance | Empagliflozin | 297 | 47 |
| Fluoxetine Hcl | Fluoxetine Hcl | 290 | 33 |
| Benztropine Mesylate | Benztropine Mesylate | 287 | 11 |
| Tramadol Hcl | Tramadol Hcl | 285 | 133 |
| Myrbetriq | Mirabegron | 279 | 17 |
| Ziprasidone Hcl | Ziprasidone Hcl | 279 | 12 |
| Amiodarone Hcl | Amiodarone Hcl | 276 | 37 |
| Ezetimibe | Ezetimibe | 267 | 29 |
| Alprazolam | Alprazolam | 266 | 70 |
| Tizanidine Hcl | Tizanidine Hcl | 258 | 34 |
| Topiramate | Topiramate | 256 | 13 |
| Meloxicam | Meloxicam | 253 | 63 |
| Ranolazine Er | Ranolazine | 244 | 15 |
| Paroxetine Hcl | Paroxetine Hcl | 243 | 17 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 236 | 44 |
| Unifine Safecontrol Pen Needle | Pen Needle,dual Safety,diabetc | 231 | 74 |
| Sevelamer Carbonate | Sevelamer Carbonate | 230 | 17 |
| Entresto | Sacubitril/Valsartan | 226 | 28 |
| Oxybutynin Chloride | Oxybutynin Chloride | 220 | 19 |
| Fenofibrate | Fenofibrate Nanocrystallized | 218 | 16 |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 216 | 65 |
| Methylprednisolone | Methylprednisolone | 214 | 172 |
| Farxiga | Dapagliflozin Propanediol | 211 | 21 |
| Glipizide | Glipizide | 207 | 51 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 207 | 36 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 200 | 143 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 198 | 43 |
| Azithromycin | Azithromycin | 197 | 145 |
| Carbamazepine | Carbamazepine | 194 | 11 |
| Desmopressin Acetate | Desmopressin Acetate | 190 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 183 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 181 | 20 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 180 | 106 |
| Haloperidol | Haloperidol | 180 | 11 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 179 | 99 |
| Doxycycline Hyclate | Doxycycline Hyclate | 177 | 87 |
| Primidone | Primidone | 174 | 14 |
| Humalog Kwikpen U-100 | Insulin Lispro | 173 | 19 |
| Aripiprazole | Aripiprazole | 171 | 20 |
| Propranolol Hcl Er | Propranolol Hcl | 165 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 164 | 91 |
| Ozempic | Semaglutide | 161 | 36 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 158 | 67 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 155 | 53 |
| Latanoprost | Latanoprost | 154 | 40 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 147 | suppressed |
| Celecoxib | Celecoxib | 146 | 27 |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 143 | 18 |
| Trulicity | Dulaglutide | 143 | 29 |
| Clonazepam | Clonazepam | 140 | 24 |
| Metformin Hcl Er | Metformin Hcl | 140 | 14 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 139 | 57 |
| Labetalol Hcl | Labetalol Hcl | 139 | suppressed |
| Januvia | Sitagliptin Phosphate | 136 | 13 |
| Chlorthalidone | Chlorthalidone | 133 | 14 |
| Insulin Aspart Flexpen | Insulin Aspart | 133 | 71 |
| Amitriptyline Hcl | Amitriptyline Hcl | 132 | 18 |
| Rivastigmine | Rivastigmine | 130 | 22 |
| Oxycodone Hcl | Oxycodone Hcl | 129 | 35 |
| Sotalol | Sotalol Hcl | 129 | suppressed |
| Linzess | Linaclotide | 128 | 35 |
| Levemir Flexpen | Insulin Detemir | 124 | 21 |
| Cephalexin | Cephalexin | 119 | 70 |
| Digoxin | Digoxin | 115 | suppressed |
| Mounjaro | Tirzepatide | 114 | 25 |
| Bupropion Xl | Bupropion Hcl | 111 | 15 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 110 | 53 |
| Nortriptyline Hcl | Nortriptyline Hcl | 107 | 14 |
| Fenofibrate | Fenofibrate | 106 | 35 |
| Lovastatin | Lovastatin | 106 | 11 |
| Bupropion Hcl Sr | Bupropion Hcl | 105 | 13 |
| Cilostazol | Cilostazol | 103 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 100 | 24 |
| Lactulose | Lactulose | 100 | 20 |
| Glimepiride | Glimepiride | 99 | 31 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 99 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 98 | suppressed |
| Darifenacin Er | Darifenacin Hydrobromide | 94 | suppressed |
| Novolog | Insulin Aspart | 89 | 22 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 87 | 44 |
| Albuterol Sulfate | Albuterol Sulfate | 86 | 31 |
| Rivastigmine | Rivastigmine Tartrate | 85 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 85 | 31 |
| Pioglitazone Hcl | Pioglitazone Hcl | 83 | 13 |
| Fluconazole | Fluconazole | 82 | 58 |
| Lithium Carbonate | Lithium Carbonate | 82 | suppressed |
| Rexulti | Brexpiprazole | 82 | suppressed |
| Thioridazine Hcl | Thioridazine Hcl | 81 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 80 | 22 |
| Bupropion Hcl | Bupropion Hcl | 78 | suppressed |
| Pentoxifylline | Pentoxifylline | 77 | suppressed |
| Budesonide | Budesonide | 75 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 75 | 19 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 75 | 21 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 73 | 32 |
| Scopolamine | Scopolamine | 73 | 12 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 70 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 70 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 70 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 68 | suppressed |
| Lubiprostone | Lubiprostone | 68 | suppressed |
| Metolazone | Metolazone | 67 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 67 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 66 | 11 |
| Colesevelam Hcl | Colesevelam Hcl | 65 | suppressed |
| Methocarbamol | Methocarbamol | 65 | 17 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 64 | 23 |
| Roflumilast | Roflumilast | 63 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 62 | 19 |
| Synthroid | Levothyroxine Sodium | 62 | 12 |
| Warfarin Sodium | Warfarin Sodium | 62 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 60 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 60 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 58 | 12 |
| Bromocriptine Mesylate | Bromocriptine Mesylate | 58 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 57 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 57 | suppressed |
| Invokana | Canagliflozin | 57 | suppressed |
| Diazepam | Diazepam | 56 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 55 | suppressed |
| Mresvia | Rsv Vaccine, Pref, Mrna/Pf | 55 | 55 |
| Nyamyc | Nystatin | 55 | 35 |
| Cinacalcet Hcl | Cinacalcet Hcl | 54 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 54 | 15 |
| Metoclopramide Hcl | Metoclopramide Hcl | 54 | suppressed |
| Azathioprine | Azathioprine | 53 | suppressed |
| Calcitriol | Calcitriol | 53 | suppressed |
| Levofloxacin | Levofloxacin | 53 | 38 |
| Metronidazole | Metronidazole | 53 | 35 |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 53 | 11 |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 52 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 52 | 11 |
| Vascepa | Icosapent Ethyl | 52 | suppressed |
| Acetazolamide Er | Acetazolamide | 51 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 51 | suppressed |
| Methazolamide | Methazolamide | 51 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 50 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 50 | suppressed |
| Bicalutamide | Bicalutamide | 49 | suppressed |
| Hydrocortisone | Hydrocortisone | 49 | 12 |
| Paricalcitol | Paricalcitol | 49 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 48 | suppressed |
| Amantadine | Amantadine Hcl | 47 | suppressed |
| Temazepam | Temazepam | 46 | 16 |
| Calcium Acetate | Calcium Acetate | 45 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 45 | 13 |
| Fentanyl | Fentanyl | 45 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 44 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 43 | suppressed |
| Lamivudine | Lamivudine | 42 | suppressed |
| Timolol Maleate | Timolol Maleate | 42 | 11 |
| Abacavir | Abacavir Sulfate | 41 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 41 | 14 |
| Glipizide Er | Glipizide | 40 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 39 | suppressed |
| Humalog | Insulin Lispro | 39 | suppressed |
| Nystatin | Nystatin | 39 | 27 |
| Glucagon Emergency Kit | Glucagon | 38 | 16 |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 38 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 37 | 18 |
| Doxepin Hcl | Doxepin Hcl | 37 | suppressed |
| Novolog Flexpen | Insulin Aspart | 37 | 15 |
| Nystop | Nystatin | 37 | 21 |
| Amoxicillin | Amoxicillin | 36 | 23 |
| Diclofenac Sodium | Diclofenac Sodium | 36 | 15 |
| Disulfiram | Disulfiram | 36 | suppressed |
| Nitroglycerin | Nitroglycerin | 36 | 29 |
| Estradiol | Estradiol | 35 | suppressed |
| Ibuprofen | Ibuprofen | 35 | 13 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 34 | suppressed |
| Insulin Aspart | Insulin Aspart | 34 | 20 |
| Valacyclovir | Valacyclovir Hcl | 34 | 15 |
| Ceftriaxone | Ceftriaxone Sodium | 33 | 28 |
| Colchicine | Colchicine | 33 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 33 | suppressed |
| Ketoconazole | Ketoconazole | 32 | 18 |
| Promethazine Hcl | Promethazine Hcl | 32 | 11 |
| Acyclovir | Acyclovir | 31 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 31 | 11 |
| Mupirocin | Mupirocin | 31 | 20 |
| Ventolin Hfa | Albuterol Sulfate | 31 | 11 |
| Victoza 2-Pak | Liraglutide | 31 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 30 | suppressed |
| Folic Acid | Folic Acid | 29 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 29 | 28 |
| Solifenacin Succinate | Solifenacin Succinate | 29 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 29 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 28 | suppressed |
| Trospium Chloride Er | Trospium Chloride | 28 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 27 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 27 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 27 | 27 |
| Phenytoin | Phenytoin | 27 | suppressed |
| Torsemide | Torsemide | 27 | 12 |
| Nebivolol Hcl | Nebivolol Hcl | 26 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 26 | suppressed |
| Ondansetron Odt | Ondansetron | 26 | 17 |
| Enalapril Maleate | Enalapril Maleate | 25 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 25 | suppressed |
| Meropenem-0.9% Nacl | Meropenem-0.9% Sodium Chloride | 25 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 14 |
| Brilinta | Ticagrelor | 24 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 24 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 24 | suppressed |
| Rybelsus | Semaglutide | 24 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 23 | suppressed |
| Xifaxan | Rifaximin | 23 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 22 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 22 | 12 |
| Daptomycin | Daptomycin | 22 | suppressed |
| Erythromycin | Erythromycin Base | 22 | 14 |
| Fycompa | Perampanel | 22 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 22 | suppressed |
| Renvela | Sevelamer Carbonate | 22 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 21 | suppressed |
| Ramipril | Ramipril | 21 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 21 | 18 |
| Testosterone Cypionate | Testosterone Cypionate | 21 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 20 | 13 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 20 | 17 |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 20 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 20 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 19 | suppressed |
| Mirabegron Er | Mirabegron | 19 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 19 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 18 | suppressed |
| Fiasp | Insulin Aspart (Niacinamide) | 18 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Irbesartan | Irbesartan | 18 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 18 | suppressed |
| Phenobarbital | Phenobarbital | 18 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 18 | suppressed |
| Verapamil Er | Verapamil Hcl | 18 | suppressed |
| Cefdinir | Cefdinir | 17 | 13 |
| Ceftriaxone | Ceftriaxone In Is-Osm Dextrose | 17 | suppressed |
| Febuxostat | Febuxostat | 17 | suppressed |
| Levemir | Insulin Detemir | 17 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 17 | 12 |
| Trospium Chloride | Trospium Chloride | 17 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 17 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 16 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 16 | suppressed |
| Isosorbide Mononitrate | Isosorbide Mononitrate | 16 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 15 | suppressed |
| Insulin Lispro | Insulin Lispro | 15 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 15 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 15 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 15 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 14 | suppressed |
| Dutasteride | Dutasteride | 14 | suppressed |
| Formoterol Fumarate | Formoterol Fumarate | 14 | suppressed |
| Glatopa | Glatiramer Acetate | 14 | suppressed |
| Glyxambi | Empagliflozin/Linagliptin | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Letrozole | Letrozole | 14 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 14 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 14 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 13 | 12 |
| Atomoxetine Hcl | Atomoxetine Hcl | 13 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 13 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 13 | suppressed |
| Indapamide | Indapamide | 13 | suppressed |
| Jantoven | Warfarin Sodium | 13 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 13 | 13 |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Spironolactone-Hctz | Spironolact/Hydrochlorothiazid | 13 | suppressed |
| Vancomycin Hcl | Vancomycin/Water For Inj (Peg) | 13 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Cyclosporine | Cyclosporine | 12 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 12 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 12 | suppressed |
| Methimazole | Methimazole | 12 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 12 | suppressed |
| Nortrel | Norethindrone-Ethin. Estradiol | 12 | suppressed |
| Rhopressa | Netarsudil Mesylate | 12 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 11 | suppressed |
| Creon | Lipase/Protease/Amylase | 11 | suppressed |
| Insulin Syringe | Syringe-Needle,insulin,0.5 Ml | 11 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 11 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl/Pf | 11 | suppressed |
| Movantik | Naloxegol Oxalate | 11 | suppressed |
| Ropinirole Er | Ropinirole Hcl | 11 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Verapamil Sr | Verapamil Hcl | 11 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $1,126.36 · 28 records | Stryker Corporation | ABRYSVO, ACCRUFER, Auvelity, FREESTYLE LIBRE, Flector, Fluad, Flucelvax, Licart, MAKO, MOUNJARO, NURTEC ODT, NUZYRA, Ozempic, PREVNAR 20, REXULTI, Rybelsus, TZIELD, Tirosint, Veozah, WATCHMAN Access System, Wegovy, ZAVZPRET, ZEPBOUND | 11 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Mounjaro play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Astellas Pharma US Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error